MIM 2525
COMPONENT COMPLEMENT SYSTEM
The complement system
Nomenclature of Complement Components
 Complement components are designated as C1 to
C9
 Products of reactions are designated asAg –Ab –
C e.g.Ag-Ab-C1423
 Components , which acquire enzymatic or
biological activity, are indicated by a bar over the
component e.g. C1 is the enzymatically-activated
form of C1
The complement system
 Fragments of complement cleaved during the
reaction are indicated by lower case letter, e.g.
C3a, C3b
 Inactivated forms of complement components are
indicated by a suffix‘i’ e.g. C3i
The complement system
 Complex group of proteins present in normal
humans and animals consisting approximately of 5
to 10 % of human serum proteins.
 it’s an integral part of the body’s immune system
that has the ability to
- lyse red blood cells (haemolytic activity)
- destroy Gram negative bacteria ( bacteriolytic
activity )
- kill Gram positive bacteria without lysis
(bactericidal activity)
- inactivate viruses ( virus neutralization)
- damage tumour cells
Ag – Ab complexes absorb it non specifically and
mediate a number of immunological and biological
activities
The complement system
 Derived from experiments performed by Jules
Bordet shortly after the discovery of antibodies
 He demonstrated that if fresh serum containing an
antibacterial antibodies was added to bacteria at
37⁰C , the bacteria were lysed.
 However, if the serum was heated at 56⁰C or
more, it lost its lytic capacity.
The complement system
 The loss was NOT due to decay of antibodies
activity because antibodies are heat stable.
 He concluded that the serum contained another
heat–labile component that assisted or
complemented the lytic function of antibodies.
 This component was later given the name
complement.
The complement system
 Becomes effective when activated
 Out of the more than 20 proteins, 11 proteins are
mostly involved in the reactions, B (serine protease),
C1 to C9 and D (D - adipsin, serine protease)
The complement cascade.
 The complement cascade may be activated
by one of the three pathways.
The alternative pathway.
The classical pathway.
The lectin pathway.
The complement cascade.
 The complement pathways are activated
differently but all of them result in the
generation of enzyme complexes that
cleave the most abundant complement
protein C3.
Activation of pathways.
Alternative pathway.
 Bacterial endotoxins(LPS), yeast cells, cobra
venom
Classic pathway.
 Ag – Ab rxn
Lectin pathway
• Mannose residues on bacterial cell walls
• Neisseria, Candida, Salmonella
Alternative pathway
 Cell surface substances such as bacterial
lipopolysaccharides (endotoxin), teichoic acid
from g+ bacteria , fungal cell walls and viral
envelopes can activate the complement system
without antibody complexes .
 The pathway starts from C 3 which undergoes
spontaneous hydrolysis that yields C3a and C3b.
 C3b binds to foreign surface antigens & to Factor B
Alternative pathway
 Binding of C3b exposes a site on Factor B that acts as a
substrate for Factor D.
 Factor D cleaves the C3b –bound Factor B releasing a small
fragment (Ba) and generates C3bBb.
 This complex has C3 convertase activity. ( this complex is stabilized
by binding to properdin )
The classical pathway
 Antigen - antibody complexes activate CI to form protease
which cleaves C2 and C4 to form C4b , C2a complex, (C3
covertase.)
 This complex cleaves C3 molecules into C3a and C3b
fragments.
 C3a is an anaphylatoxin and C3b forms a complex
with C4b , C2a producing a new enzyme called C5
convertase (C4b ,C2a ,C3b) that cleaves C5 into C5a
and C5b.
The lectin pathway
 Mannan binding lectins (MBL) also known as mannose
binding lectins (MBL) bind to the surface of bacteria
bearing mannan (polymer of a sugar mannose) (e.g
Salmonella, Neisseria, Candida albicans)
 MBL is an acute phase protein produced in
inflammatory responses & bind to the surface
of pathogens .
The lectin pathway
 This activates MBL - associated serine proteases
(MASP-1 & 2 ) similar to ( C1r and C1s) , that
BIND TO :
MBL & the complex formed cleaves C4 & C2.
 This means of activating C2 –C4 to form C5- covertase
without specific antibody represents an important
innate defense mechanism .
The role of different complement
components in immunity.
 In addition, products of Complement
facilitates the activation of B-lymphocytes
and the production of antibodies.
The role of Complement system
in host defense.
Opsonization and phagocytosis.
 C3b or C4b coat microbe hence phagocytosis
Stimulation of inflammatory responses
• C5a, C4a and C3a induce inflammation by
activating mast cells and neutrophils.
Complement- mediated cytolysis mediated by the
Membrane attack complex (MAC).
The role of Complement system
in host defense
In neutrophils,C5a stimulates
 Motility,
 Firm adhesion to endothelial cells.
 Respiratory burst and production of reactive oxygen
intermediates.
 C5a may act directly on vascular endothelial
cells and induce increased vascular permeability and
expression of p- selectin which promotes neutrophil
binding.
 C5a is the most important mediator of mast
cell degranulation
Regulation of Complement
 Regulation is needed because spontaneous and
continuous generation of complements can
damage normal cells and tissues.
 Regulation is mediated by cells and membrane
proteins.
 Inhibiting the formation of C3 convertase
 Breaking down and inactivating C3 and C5
convertases.
 Inhibiting the formation of MAC.
Evasion of complement by
microorganisms
 Pathogens have evolved diverse mechanisms for
evading the complement system.
 Expressing thick cell walls or capsules to avoid MAC
e.g. gram positive bacteria and fungi.
 Recruiting host complement regulatory proteins.
 Expressing sialic acid which can inhibit alternative
pathway by recruiting factor H which displaces C3b
from Bb.
Evasion of complement by
microorganisms
 Plasma protein called C1 inhibitor (C1 INH)
inhibit the formation of MAC
 Synthesizing proteins which are antagonist of the
C5a.(Staph spp).
Evasion of complements by
microorganisms
Expressing sialic acid which can inhibit
alternative pathway by recruiting factor H
which displaces C3b from Bb.
Evasion of complement by
microorganisms
 Scavenging sialic acid from the host and
enzymatically transfering the sugar to their cell
surfaces.
 Synthesizing proteins which are antagonists of the
C5a.(Staph spp).
Clinical Aspects
 In miss- matched blood transfusion reactions
complement is activated to cause haemolysis and large
amounts of anaphylatoxins and membrane attack
complexes are generated.
 Immune complexes bind complement and its levels are low
in immune- complex diseases e.g. acute
glomerulonephritis, systemic lupus erythematosus (SLE).
 Patients with genetic deficiencies of complement
suffer from immune-complex diseases & recurrent
infections by pyogenic bacteria .

COMPLEMENT SYSTEM EDEN cdhkjyuuy 2019.pdf

  • 1.
  • 2.
    The complement system Nomenclatureof Complement Components  Complement components are designated as C1 to C9  Products of reactions are designated asAg –Ab – C e.g.Ag-Ab-C1423  Components , which acquire enzymatic or biological activity, are indicated by a bar over the component e.g. C1 is the enzymatically-activated form of C1
  • 3.
    The complement system Fragments of complement cleaved during the reaction are indicated by lower case letter, e.g. C3a, C3b  Inactivated forms of complement components are indicated by a suffix‘i’ e.g. C3i
  • 4.
    The complement system Complex group of proteins present in normal humans and animals consisting approximately of 5 to 10 % of human serum proteins.  it’s an integral part of the body’s immune system that has the ability to - lyse red blood cells (haemolytic activity) - destroy Gram negative bacteria ( bacteriolytic activity )
  • 5.
    - kill Grampositive bacteria without lysis (bactericidal activity) - inactivate viruses ( virus neutralization) - damage tumour cells Ag – Ab complexes absorb it non specifically and mediate a number of immunological and biological activities
  • 6.
    The complement system Derived from experiments performed by Jules Bordet shortly after the discovery of antibodies  He demonstrated that if fresh serum containing an antibacterial antibodies was added to bacteria at 37⁰C , the bacteria were lysed.  However, if the serum was heated at 56⁰C or more, it lost its lytic capacity.
  • 7.
    The complement system The loss was NOT due to decay of antibodies activity because antibodies are heat stable.  He concluded that the serum contained another heat–labile component that assisted or complemented the lytic function of antibodies.  This component was later given the name complement.
  • 8.
    The complement system Becomes effective when activated  Out of the more than 20 proteins, 11 proteins are mostly involved in the reactions, B (serine protease), C1 to C9 and D (D - adipsin, serine protease)
  • 9.
    The complement cascade. The complement cascade may be activated by one of the three pathways. The alternative pathway. The classical pathway. The lectin pathway.
  • 10.
    The complement cascade. The complement pathways are activated differently but all of them result in the generation of enzyme complexes that cleave the most abundant complement protein C3.
  • 11.
    Activation of pathways. Alternativepathway.  Bacterial endotoxins(LPS), yeast cells, cobra venom Classic pathway.  Ag – Ab rxn Lectin pathway • Mannose residues on bacterial cell walls • Neisseria, Candida, Salmonella
  • 12.
    Alternative pathway  Cellsurface substances such as bacterial lipopolysaccharides (endotoxin), teichoic acid from g+ bacteria , fungal cell walls and viral envelopes can activate the complement system without antibody complexes .  The pathway starts from C 3 which undergoes spontaneous hydrolysis that yields C3a and C3b.  C3b binds to foreign surface antigens & to Factor B
  • 13.
    Alternative pathway  Bindingof C3b exposes a site on Factor B that acts as a substrate for Factor D.  Factor D cleaves the C3b –bound Factor B releasing a small fragment (Ba) and generates C3bBb.  This complex has C3 convertase activity. ( this complex is stabilized by binding to properdin )
  • 14.
    The classical pathway Antigen - antibody complexes activate CI to form protease which cleaves C2 and C4 to form C4b , C2a complex, (C3 covertase.)  This complex cleaves C3 molecules into C3a and C3b fragments.  C3a is an anaphylatoxin and C3b forms a complex with C4b , C2a producing a new enzyme called C5 convertase (C4b ,C2a ,C3b) that cleaves C5 into C5a and C5b.
  • 15.
    The lectin pathway Mannan binding lectins (MBL) also known as mannose binding lectins (MBL) bind to the surface of bacteria bearing mannan (polymer of a sugar mannose) (e.g Salmonella, Neisseria, Candida albicans)  MBL is an acute phase protein produced in inflammatory responses & bind to the surface of pathogens .
  • 16.
    The lectin pathway This activates MBL - associated serine proteases (MASP-1 & 2 ) similar to ( C1r and C1s) , that BIND TO : MBL & the complex formed cleaves C4 & C2.  This means of activating C2 –C4 to form C5- covertase without specific antibody represents an important innate defense mechanism .
  • 17.
    The role ofdifferent complement components in immunity.  In addition, products of Complement facilitates the activation of B-lymphocytes and the production of antibodies.
  • 18.
    The role ofComplement system in host defense. Opsonization and phagocytosis.  C3b or C4b coat microbe hence phagocytosis Stimulation of inflammatory responses • C5a, C4a and C3a induce inflammation by activating mast cells and neutrophils. Complement- mediated cytolysis mediated by the Membrane attack complex (MAC).
  • 19.
    The role ofComplement system in host defense In neutrophils,C5a stimulates  Motility,  Firm adhesion to endothelial cells.  Respiratory burst and production of reactive oxygen intermediates.  C5a may act directly on vascular endothelial cells and induce increased vascular permeability and expression of p- selectin which promotes neutrophil binding.  C5a is the most important mediator of mast cell degranulation
  • 20.
    Regulation of Complement Regulation is needed because spontaneous and continuous generation of complements can damage normal cells and tissues.  Regulation is mediated by cells and membrane proteins.  Inhibiting the formation of C3 convertase  Breaking down and inactivating C3 and C5 convertases.  Inhibiting the formation of MAC.
  • 21.
    Evasion of complementby microorganisms  Pathogens have evolved diverse mechanisms for evading the complement system.  Expressing thick cell walls or capsules to avoid MAC e.g. gram positive bacteria and fungi.  Recruiting host complement regulatory proteins.  Expressing sialic acid which can inhibit alternative pathway by recruiting factor H which displaces C3b from Bb.
  • 22.
    Evasion of complementby microorganisms  Plasma protein called C1 inhibitor (C1 INH) inhibit the formation of MAC  Synthesizing proteins which are antagonist of the C5a.(Staph spp).
  • 23.
    Evasion of complementsby microorganisms Expressing sialic acid which can inhibit alternative pathway by recruiting factor H which displaces C3b from Bb.
  • 24.
    Evasion of complementby microorganisms  Scavenging sialic acid from the host and enzymatically transfering the sugar to their cell surfaces.  Synthesizing proteins which are antagonists of the C5a.(Staph spp).
  • 25.
    Clinical Aspects  Inmiss- matched blood transfusion reactions complement is activated to cause haemolysis and large amounts of anaphylatoxins and membrane attack complexes are generated.  Immune complexes bind complement and its levels are low in immune- complex diseases e.g. acute glomerulonephritis, systemic lupus erythematosus (SLE).  Patients with genetic deficiencies of complement suffer from immune-complex diseases & recurrent infections by pyogenic bacteria .